Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

3.15
Delayed Data
As of Jul 26
 +0.02 / +0.64%
Today’s Change
2.65
Today|||52-Week Range
5.87
-21.45%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues12.5K32.5K12.0K12.5K
 
 
 
 
 
Depreciation And Amortization219.0K223.2K220.5K217.3K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses10.6M10.1M9.7M10.1M
 
 
 
 
 
Research And Development6.7M6.6M6.4M6.5M
 
 
 
 
 
Total Operating Expenses10.8M10.4M9.9M10.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.8M-10.3M-9.9M-10.3M
 
 
 
 
 
Other Expenses177.9K0.00-55.0K-3.5K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.6M-10.0M-9.8M-10.2M
 
 
 
 
 
Net Income-10.6M-10.0M-9.8M-10.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS41.9M42.0M42.0M42.1M
 
 
 
 
 
Shares To Calculate EPS Diluted41.9M42.0M42.0M42.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.25-$0.24-$0.23-$0.24
 
 
 
 
 
EPS Diluted-$0.25-$0.24-$0.23-$0.24